New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 26, 2014
07:34 EDTNAVBNavidea, collaborators announce NAV4694 presentations
Navidea Biopharmaceuticals announced that collaborators from the Department of Nuclear Medicine at University Hospital of Leipzig are planning presentations highlighting Navidea’s PET imaging agent, NAV4694, at the German Society of Nuclear Medicine Annual Congress in Hannover, Germany. NAV4694 is an investigational Fluorine-18 labeled beta-amyloid imaging agent currently being evaluated in late stage clinical trials for use as an aid in differential diagnosis and to monitor progression of Alzheimer's disease, Mild Cognitive Impairment and other forms of neurodegenerative dementia.
News For NAVB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
07:38 EDTNAVBNavidea announces presentation of Lymphoseek studies results
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use